Oct. 12, 2010 - Study To Assess Real-Life Clinical Results in 300 Patients With Bifurcation Disease in Italy - Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company’s Tryton Side Branch Stent™ System. E-Tryton Italy is one of four registries in Europe evaluating the Tryton Side Branch Stent System in real-world clinical settings.The Tryton Side Branch Stent System is designed to offer a dedicated strategy for treating atherosclerotic lesions in the side branch at the site of a bifurcation. Tryton’s highly deliverable cobalt chromium stent is deployed in the side branch artery using standard single-wire balloon expandable stent delivery system. A conventional drugeluting stent is then placed in the main vessel... [PDF] Tryton Medical's Press Release -
